original ) (raw )Efficient Lytic Infection of Human Arterial Endothelial Cells by Human Cytomegalovirus Strains
Dorothea Siegel-Axel
Journal of Virology, 2000
View PDFchevron_right
Pathogenesis of human cytomegalovirus infection and cellular targets
B. Fausto
Human Immunology, 2004
View PDFchevron_right
Serum antibody response to the gH/gL/pUL128–131 five-protein complex of human cytomegalovirus (HCMV) in primary and reactivated HCMV infections
B. Fausto
Journal of Clinical Virology, 2011
View PDFchevron_right
Neutralizing antibodies are unable to inhibit direct viral cell-to-cell spread of human cytomegalovirus
Eliud Sepulveda
Virology, 2013
View PDFchevron_right
Human Cytomegalovirus Tropism for Endothelial Cells: Not All Endothelial Cells Are Created Equal
Not All
Journal of Virology, 2006
View PDFchevron_right
Uninfected and Cytomegalic Endothelial Cells in Blood during Cytomegalovirus Infection: Effect of Acute Rejection
M.C. Harmsen
The Journal of Infectious Diseases, 2000
View PDFchevron_right
Differential kinetics of human cytomegalovirus load and antibody responses in primary infection of the immunocompetent and immunocompromised host
Elisa Gabanti
The Journal of general virology, 2015
View PDFchevron_right
Immunoaffinity Purification of a 72K Early Antigen of Human Cytomegalovirus: Analysis of Humoral and Cell-mediated Immunity to the Purified Polypeptide
Brian Rodgers
Journal of General Virology, 1987
View PDFchevron_right
Neutralization of Diverse Human Cytomegalovirus Strains Conferred by Antibodies Targets Viral gH/gL/pUL128-131 Pentameric Complex
Richard Rustandi
Journal of virology, 2017
View PDFchevron_right
Quantitative analysis of neutralizing antibody response to human cytomegalovirus in natural infection
Fengsheng Li
Vaccine, 2011
View PDFchevron_right
Cell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB): use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response
E. Butfiloski
Journal of Virology, 1990
View PDFchevron_right
Enhanced endothelial cytopathogenicity induced by a cytomegalovirus strain propagated in endothelial cells
William H Roberts
Journal of Medical Virology, 1989
View PDFchevron_right
Cytomegalovirus-specific antibodies to an immediate early antigen and a late membrane antigen and their possible role in controlling secondary cytomegalovirus infection
W. Van Der Bij
Clinical & Experimental Immunology, 2008
View PDFchevron_right
The attenuated Towne strain of human cytomegalovirus may revert to both endothelial cell tropism and leuko- (neutrophil- and monocyte-) tropism in vitro
B. Fausto
The Journal of general virology, 2002
View PDFchevron_right
Analysis of a major target of the human immune response to cytomegalovirus using monoclonal antibodies
Hh Abo
Journal of Medical Virology, 1988
View PDFchevron_right
Development of a High-Throughput Assay To Measure the Neutralization Capability of Anti-Cytomegalovirus Antibodies
Thomas Gardner
Clinical and Vaccine Immunology, 2013
View PDFchevron_right
Human Cytomegalovirus (HCMV) Infection of Endothelial Cells Promotes Naive Monocyte Extravasation and Transfer of Productive Virus To Enhance Hematogenous Dissemination of HCMV
Andrew Yurochko
Journal of Virology, 2006
View PDFchevron_right
Neutralization of Human Cytomegalovirus by Human CD13-Specific Antibodies
Debby Ham
Journal of Infectious Diseases, 1996
View PDFchevron_right
Rescue of human cytomegalovirus strain AD169 tropism for both leukocytes and human endothelial cells
B. Fausto
Journal of General Virology, 2003
View PDFchevron_right
Functional antibody response to human cytomegalovirus in immunocompetent and HIV-1 infected individuals with antibodies that inhibit virus penetration into cells and intercellular transmission of viral infection
Amparo Tamarit
Journal of Medical Microbiology, 1999
View PDFchevron_right
The US16 Gene of Human Cytomegalovirus Is Required for Efficient Viral Infection of Endothelial and Epithelial Cells
Marco De Andrea
Journal of Virology, 2012
View PDFchevron_right
Antibody responses to human cytomegalovirus proteins
Mariapaola Landini
Reviews in Medical Virology, 1992
View PDFchevron_right
In vitro selection of human cytomegalovirus variants unable to transfer virus and virus products from infected cells to polymorphonuclear leukocytes and to grow in endothelial cells
B. Fausto
The Journal of general virology, 2001
View PDFchevron_right
Human cytomegalovirus
Istvan Boldogh
Archives of Virology, 1990
View PDFchevron_right
Comparison of the Neutralizing and ELISA Antibody Titres to Human Cytomegalovirus (HCMV) in Human Sera and in Gamma Globulin Preparations
Dr. Suliman Essuman
Journal of Medical Virology, 1986
View PDFchevron_right
Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus
Stipan Jonjic
Journal of Experimental Medicine, 1994
View PDFchevron_right
Role of Neutralizing Antibodies in CMV Infection: Implications for New Therapeutic Approaches
Virginia Sandonis
Trends in Microbiology, 2020
View PDFchevron_right
Antigenic domain 1 of human cytomegalovirus glycoprotein B induces a multitude of different antibodies which, when combined, results in incomplete virus neutralization
Mats Ohlin
The Journal of general virology, 1999
View PDFchevron_right
Humoral immune response to human cytomegalovirus proteins: A brief review
Peter Den Heijer
Comparative Immunology, Microbiology and Infectious Diseases, 1991
View PDFchevron_right
Early interactions between human cytomegalovirus and cells
Lena Einhorn
Archives of Virology, 1984
View PDFchevron_right
Bioactive Molecules Released From Cells Infected with the Human Cytomegalovirus
Giorgio Gribaudo
Frontiers in Microbiology, 2016
View PDFchevron_right
Polyclonal cytomegalovirus-specific antibodies not only prevent virus dissemination from the portal of entry but also inhibit focal virus spread within target tissues
Matthias Reddehase
Medical Microbiology and Immunology, 2008
View PDFchevron_right
Adult human heart microvascular endothelial cells are permissive for non-lytic infection by human cytomegalovirus
Caterina Pollara
Cardiovascular Research, 2001
View PDFchevron_right